Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning after Failed Myeloablative HCT: Factors Affecting Outcomes.

Frederic Baron, R. Storb, B. Storer, D. Maloney, M. Maris, D. Niederwieser, J. Shizuru, T. Chauncey, B. Bruno, S. Forman, P. McSweeney, R. Maziarz, M. Pulsipher, E. Agura, M. Sorror, J. Wade, B. Sandmaier

Blood (2005) 106 (11): 1143.

https://doi.org/10.1182/blood.V106.11.1143.1143

Published: 2005

Journal Articles

Efficacy of Nonmyeloablative Hematopoietic Cell Transplant (HCT) in Secondary Myelodysplastic Syndrome (MDS) and Its Impact on the Primary Disease.

F. Kerbauy, M. Maris, B. Storer, D. Maloney, D. Niederwieser, E. Agura, M. Pulsipher, T. Chauncey, R. Maziarz, S. Forman, A. Langston, J. Wade, B. Scott, J. Deeg, R. Storb, B. M. Sandmaier

Blood (2005) 106 (11): 792.

https://doi.org/10.1182/blood.V106.11.792.792

Published: 2005

Journal Articles

Hematopoietic Cell Transplants (HCT) from HLA-Matched Related (MRD) and Unrelated (URD) Donors for Patients with Hematologic Malignancies Using Low-Dose TBI Conditioning.

Blood (2005) 106 (11): 655.

https://doi.org/10.1182/blood.V106.11.655.655

Published: 2005

Journal Articles

HLA-Matched Related (MRD) or Unrelated Donor (URD) Non-Myeloablative Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Refractory and Relapsed Aggressive Non Hodgkin Lymphoma (NHL).

L. Norasetthada, M. B. Maris, B. M. Sandmaier, T. Gooley, S. Forman, E. Agura, R. T. Maziarz, J. Shizuru, D. Niederwieser, R. Storb, D. G. Maloney

Blood (2004) 104 (11): 2307.

https://doi.org/10.1182/blood.V104.11.2307.2307

Published: 2004

Journal Articles

HLA-Matched Unrelated Donor HCT after Nonmyeloablative Conditioning for Patients with Chronic Myeloid Leukemia.

Frederic Baron, M. Maris, B. Sandmaier, B. Storer, M. Stuart, P. McSweeney, J. Radich, M. Pulsipher, E. Agura, E. Petersdorf, S. Heimfeld, T. Chauncey, M.T. Little, D. Maloney, K. Blume, R. Storb

Blood (2004) 104 (11): 2755.

https://doi.org/10.1182/blood.V104.11.2755.2755

Published: 2004

Journal Articles

Unrelated Donor Peripheral Blood Stem Cell (PBSC) Transplantation Using Nonmyeloablative Conditioning and Mycophenolate Mofetil (MMF) TID Results in High Engraftment Rates.

Michael B. Maris, MD, B. M. Sandmaier, MD, B. Storer, PhD, J. Shizuru, MD, PhD, D. Maloney, MD, PhD, E. Agura, MD, PhD, D. Niederwieser, MD, M. Pulsipher, MD, R. T. Maziarz, MD, P. McSweeney, MD, J. Wade, MD, A. Langston, MD, T. Chauncey, MD, B. Bruno, MD, A. Woolfrey, MD, M.T. Little, PhD, K. Blume, MD, R. Storb, MD

Blood (2004) 104 (11): 1818.

https://doi.org/10.1182/blood.V104.11.1818.1818

Published: 2004

Journal Articles

Rare occurrence of N-ras point mutations in Philadelphia chromosome positive chronic myeloid leukemia

SJ Collins, M Howard, DF Andrews, E Agura, J Radich

Blood (1989) 73 (4): 1028–1032.

https://doi.org/10.1182/blood.V73.4.1028.1028

Published: 1989

NARROW

Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning after Failed Myeloablative HCT: Factors Affecting Outcomes.

Efficacy of Nonmyeloablative Hematopoietic Cell Transplant (HCT) in Secondary Myelodysplastic Syndrome (MDS) and Its Impact on the Primary Disease.

Hematopoietic Cell Transplants (HCT) from HLA-Matched Related (MRD) and Unrelated (URD) Donors for Patients with Hematologic Malignancies Using Low-Dose TBI Conditioning.

HLA-Matched Related (MRD) or Unrelated Donor (URD) Non-Myeloablative Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Refractory and Relapsed Aggressive Non Hodgkin Lymphoma (NHL).

HLA-Matched Unrelated Donor HCT after Nonmyeloablative Conditioning for Patients with Chronic Myeloid Leukemia.

Unrelated Donor Peripheral Blood Stem Cell (PBSC) Transplantation Using Nonmyeloablative Conditioning and Mycophenolate Mofetil (MMF) TID Results in High Engraftment Rates.

Rare occurrence of N-ras point mutations in Philadelphia chromosome positive chronic myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning after Failed Myeloablative HCT: Factors Affecting Outcomes.

Efficacy of Nonmyeloablative Hematopoietic Cell Transplant (HCT) in Secondary Myelodysplastic Syndrome (MDS) and Its Impact on the Primary Disease.

Hematopoietic Cell Transplants (HCT) from HLA-Matched Related (MRD) and Unrelated (URD) Donors for Patients with Hematologic Malignancies Using Low-Dose TBI Conditioning.

HLA-Matched Related (MRD) or Unrelated Donor (URD) Non-Myeloablative Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Refractory and Relapsed Aggressive Non Hodgkin Lymphoma (NHL).

HLA-Matched Unrelated Donor HCT after Nonmyeloablative Conditioning for Patients with Chronic Myeloid Leukemia.

Unrelated Donor Peripheral Blood Stem Cell (PBSC) Transplantation Using Nonmyeloablative Conditioning and Mycophenolate Mofetil (MMF) TID Results in High Engraftment Rates.

Rare occurrence of N-ras point mutations in Philadelphia chromosome positive chronic myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only